Seda Pharmaceutical Development Services is a privately held company founded in 2015 and headquartered in Cheadle, Greater Manchester, United Kingdom. The organisation delivers scientific consultancy, laboratory, modelling and regulatory support across the pharmaceutical development lifecycle. Its mission is to add value to clients’ drug development programmes by applying high-level scientific expertise in pharmaceutical technology, drug metabolism and pharmacokinetics (DMPK) and clinical pharmacology. Seda’s approach is designed to help partners make informed decisions that balance risk, cost and timing, and to support the efficient translation of drug candidates from early development through to clinical supply and regulatory submission.

Key Products and Services

Pharmaceutical Development Consultancy: Scientific guidance on formulation strategy, product design and regulatory requirements.

Laboratory Services: Experimental support, rapid screening and testing of formulations.

Modelling Services: In silico and pharmacokinetic modelling to predict human performance and optimise dose selection.

Clinical Pharmacology Support: Expertise in DMPK, clinical study design and interpretation of pharmacological data.

Regulatory and CMC Advisory: Advice and planning for chemistry, manufacturing and controls (CMC) and regulatory strategies.

Product Supply Oversight: Technical oversight and project management for clinical supply, often in conjunction with GMP manufacturing partners or its own clinical manufacturing services.

Seda operates at the intersection of scientific consultancy and practical delivery, offering a blend of strategic expertise and technical support tailored to the needs of pharmaceutical and biotech sponsors. With capabilities spanning early research through clinical supply transition, Seda is structured to help organisations de-risk programmes, accelerate timelines and make well-informed development decisions. Its scientific leadership and integrated service model aim to support clients in bringing effective medicines to patients efficiently and with regulatory confidence.